ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $456,845 | -20.7% | 24,522 | -5.0% | 0.02% | -19.0% |
| Q2 2022 | $576,000 | +6.3% | 25,816 | +106.0% | 0.02% | -40.0% |
| Q2 2021 | $542,000 | -28.9% | 12,531 | -32.9% | 0.04% | -7.9% |
| Q1 2021 | $762,000 | +12.2% | 18,670 | +24.4% | 0.04% | +31.0% |
| Q4 2020 | $679,000 | +9.7% | 15,010 | -14.2% | 0.03% | 0.0% |
| Q3 2020 | $619,000 | -23.4% | 17,496 | -18.3% | 0.03% | -29.3% |
| Q2 2020 | $808,000 | +38.6% | 21,406 | +6.1% | 0.04% | -2.4% |
| Q1 2020 | $583,000 | +64.7% | 20,175 | +195.1% | 0.04% | +162.5% |
| Q4 2019 | $354,000 | -48.3% | 6,836 | -45.2% | 0.02% | -54.3% |
| Q3 2019 | $685,000 | -17.7% | 12,482 | -39.1% | 0.04% | -23.9% |
| Q2 2019 | $832,000 | -6.5% | 20,492 | -30.4% | 0.05% | -14.8% |
| Q1 2019 | $890,000 | +16.0% | 29,423 | +22.7% | 0.05% | -10.0% |
| Q2 2018 | $767,000 | – | 23,972 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trigran Investments, Inc. | 1,154,183 | $25,761,000 | 3.00% |
| CAPITAL MANAGEMENT CORP /VA | 275,130 | $6,141,000 | 1.52% |
| Kent Lake Capital LLC | 98,570 | $2,200,000 | 1.21% |
| DIKER MANAGEMENT LLC | 21,835 | $487,000 | 0.60% |
| Portolan Capital Management | 235,972 | $5,267,000 | 0.53% |
| Riverwater Partners LLC | 12,466 | $278,000 | 0.28% |
| Ranger Investment Management | 139,661 | $3,117,000 | 0.24% |
| Invenomic Capital Management LP | 144,287 | $3,220,000 | 0.23% |
| CHATHAM CAPITAL GROUP, INC. | 23,787 | $531,000 | 0.12% |
| Teton Advisors, Inc. | 22,000 | $491,000 | 0.10% |